The Health Care M&A Monthly: The Month In Deals: August Posts 68 Deals Worth $4 Billion
Email Editor The month of August saw a total of 68 mergers and acquisitions announced in 13 sectors of the health care industry. The month’s deal volume dropped ever so slightly from July’s tally of 69 deals. The nine sectors of the health care services segment...The Health Care M&A Monthly: Mylan Buys Matrix For $736 million: Buys Indian Firm To Enter Asian and European Markets
Email Editor Over the past year, we have covered deals in which Indian pharmaceutical companies stretched their wings and made acquisitions in Europe and the United States. With the dismantling of the “Permit Raj”—a hornet’s nest of bureaucracy and...The Health Care M&A Monthly: The Month in Deals –
July Sees 69 Deals Worth A Combined $35.5 Billion Email Editor The month of July saw a total of 69 mergers and acquisitions announced in 13 sectors of the health care industry, down 17% from the 81 deals announced in June. The nine sectors of the services segment...The Health Care M&A Monthly: One For the Record Book–
HCA Agrees To Be Taken Private For $33 Billion Email Editor For the second time in its history, hospital operator HCA, Inc. (NYSE: HCA) has agreed to be taken private. This time a group of private equity firms, along with HCA management and the founding Frist family,...The Health Care M&A Monthly: Bristol-Myers Squibb Builds a Bridge to New Revenues
After some weeks of speculation in the press, Bristol-Myers Squibb (NYSE: BMY) finally announced it would buy The DuPont Pharmaceutical Company, a subsidiary of E. I. Du Pont De Nemours (NYSE: DD), for $7.8 billion in cash. This deal advances both companies’ plans to...Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
